Get started
Author

Daniel Fellows Pease

Observed names: D. Pease, Dan Pease, Daniel F Pease, Daniel F. Pease, Daniel Pease, Pease, Daniel F
ORCID: 0000-0002-1840-7728
Observed ORCID: 0000-0002-1840-7728
OpenAlex ID: A5014289302
Oncolytic Viral Therapy for Mesothelioma
2017 · Daniel F. Pease, Robert A. Kratzke · Frontiers in Oncology · 45
PDF
Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer
2021 · Shijia Zhang, Daniel F Pease, et al. · Clinical Medicine Insights Oncology · 22
PDF
Impact of antibiotics and proton pump inhibitors on clinical outcomes of immune check point blockers in advanced non-small cell lung cancers and metastatic renal cell cancer.
2019 · Amit Kulkarni, Manoj Kumar, et al. · Journal of Clinical Oncology · 20
Differences in community and academic practice patterns for newly diagnosed myelodysplastic syndromes (MDS) patients
2015 · Daniel F. Pease, Julie A. Ross, et al. · Cancer Epidemiology · 17
Development of cutaneous squamous cell carcinoma after prolonged exposure to pegylated liposomal doxorubicin and hand–foot syndrome: a newly recognized toxicity
2019 · Daniel F. Pease, Bruce A. Peterson, et al. · Cancer Chemotherapy and Pharmacology · 12
Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high‐risk myelodysplastic syndromes: Challenges and opportunities in implementation
2021 · Erica D. Warlick, Celalettin Ustun, et al. · Cancer · 7
Treatment of mantle cell lymphoma in older adults
2018 · Daniel F. Pease, Vicki A. Morrison · Journal of Geriatric Oncology · 7
BTCRC-HN17-111, A phase 2 trial of ADT (goserelin) in combination with pembrolizumab for patients with advanced salivary gland tumors expressing androgen receptor (AR).
2022 · Manish Patel, Naomi Fujioka, et al. · Journal of Clinical Oncology · 4
A medicare database analysis of practice patterns in patients with mantle cell lymphoma
2021 · Jessalyn A. Weaver, Yi Peng, et al. · Journal of Geriatric Oncology · 4
Profound thrombocytopenia caused by abciximab infusion following.
2014 · Blake Daley, David Miranda, et al. · PubMed · 4
YTGT : A new high‐prevalence antigen in the Yt blood group system in two unrelated Native Americans and transfusion management
2022 · Nancy L. Van Buren, Barbara Gillen, et al. · Transfusion · 3
Clinical implications of the 2012 US Preventive Services Task Force (USPSTF) PSA screening recommendation in prostate cancer diagnoses and 5-year survival at a Minnesota safety net health care system.
2017 · Kevin Gale, Daniel Fellows Pease, et al. · Journal of Clinical Oncology · 2
Clinical predictors of efficacy for immune checkpoint inhibition in lung cancer patients.
2019 · Shijia Zhang, Daniel Fellows Pease, et al. · Journal of Clinical Oncology · 1
Differences In Community and Academic Practice Patterns For Newly Diagnosed Myelodysplastic Syndromes (MDS) Patients In Minnesota: A Population Based Study
2013 · Daniel Pease, Julie A Ross, et al. · Blood · 1
Case report: Caplacizumab without plasma exchange for severe thrombotic thrombocytopenic purpura
2026 · Sarah Maryon Hayes, Daniel F. Pease, et al. · Frontiers in Drug Delivery
PDF
Mammography screening and detection of early stage breast cancer in Hispanic and African American women at a Minnesota safety net healthcare system.
2017 · Daniel Fellows Pease, David T. Gilbertson, et al. · Journal of Clinical Oncology
Pott disease: when TB thinks outside the lungs.
2015 · Istiaq Mian, Dan Pease · PubMed
237 Clinician Utilization of the International Prognostic Scoring System (ipss) for Newly Diagnosed Myelodysplastic Syndromes (mds) Patients
2015 · D. Pease, J. Ross, et al. · Leukemia Research
The checkup.
2012 · Dan Pease · PubMed
Works count: 21
Citation count: 149
H-index: 7
I10-index: 5
Year
Topic
Type